Myrbetriq ER 50 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FWXNW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,821
Award facts
- Contract value 100% obligated
- $13,821.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,821.40 for Myrbetriq ER 50 mg tablets (90-count supply) on May 27, 2025, with an ultimate completion date of May 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply requirements through open competition, ranging from small-value transactions to orders exceeding $45,000. This delivery order for Myrbetriq, a medication used in the treatment of overactive bladder, represents routine pharmaceutical procurement through the company's comprehensive global pharmaceutical support vehicle with DLA.
Quick answers
Who was awarded contract SPE2DB25FWXNW?
SPE2DB25FWXNW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FWXNW worth?
The government has obligated $13,821 on SPE2DB25FWXNW.
Is contract SPE2DB25FWXNW an order under another contract?
Yes. SPE2DB25FWXNW is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWXNW competed?
The extent of competition for SPE2DB25FWXNW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award